Other compounds reported in Cannabis

Tryptophan

35public articles

3registered condition areas

All documents →

Identity & provenance

Chemical identity

C11H12N2O2 · molecular weight 204.2256

Sources: FDA GSRS / UNII · 114 LOTUS / Wikidata · wikidata-9c807e0fdee72916

1 referenced plant-occurrence records. They are identity candidates, not clinical evidence.

Research areas

Conditions found alongside this compound

Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.

Parkinson disease and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Anxiety disorders and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Depressive disorders and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Linked local records

Medicines and registered studies

Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.

Medicines with this active ingredient

No public medicine record matched.

Registered studies

1 exact source-intervention matches.

Protocol onlyENROLLING_BY_INVITATION

Investigating the Therapeutic Impact of Cannabinoids on Neuroinflammation and Neurobiological Underpinnings of Suicide Ideation in Veterans With PTSD

1-(2-[+F]fluoroethyl)-L-tryptophan

Recent research

2026

Metabolic Syndrome: From Mechanisms to Therapeutic Interventions

MedComm · Free full text

2026

Cannabidiol (CBD) modulates the serotonin-kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats.

Pharmacological Reports · Free full text

2025

Selective Influence of Hemp Fiber Ingestion on Post-Exercise Gut Permeability: A Metabolomics-Based Analysis.

Nutrients · Free full text

2025

Untargeted Metabolomics and Chemometrics Elucidate Dynamic Plasma Profile Changes Induced by Cocoa Shell in Female Rats.

Nutrients · Free full text

2025

Binding Affinity of Synthetic Cannabinoids to Human Serum Albumin: Site Characterization and Interaction Insights.

Pharmaceuticals · Free full text

2025

Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism.

Acta Pharmacologica Sinica · Free full text

2025

The role of the intestinal microbiome in cognitive decline in patients with kidney disease.

Nephrology Dialysis Transplantation · Free full text · non-commercial reuse

Tryptophan

Chemical identity

Conditions found alongside this compound

Parkinson disease and cannabinoids

Anxiety disorders and cannabinoids

Depressive disorders and cannabinoids

Medicines and registered studies

Medicines with this active ingredient

Registered studies

Investigating the Therapeutic Impact of Cannabinoids on Neuroinflammation and Neurobiological Underpinnings of Suicide Ideation in Veterans With PTSD

Recent research

Metabolic Syndrome: From Mechanisms to Therapeutic Interventions

Cannabidiol (CBD) modulates the serotonin-kynurenine metabolic balance in the brain of morphine-tolerant neuropathic rats.

Selective Influence of Hemp Fiber Ingestion on Post-Exercise Gut Permeability: A Metabolomics-Based Analysis.

Untargeted Metabolomics and Chemometrics Elucidate Dynamic Plasma Profile Changes Induced by Cocoa Shell in Female Rats.

Binding Affinity of Synthetic Cannabinoids to Human Serum Albumin: Site Characterization and Interaction Insights.

Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism.

The role of the intestinal microbiome in cognitive decline in patients with kidney disease.

Treats containing cannabidiol, L-tryptophan and α-casozepine have a mild stress-reducing effect in dogs.

Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms.

Gene Variant Frequencies of IDO1, IDO2, TDO, and KMO in Substance Use Disorder Cohorts.

Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice.

Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder